Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Arrowhead Pharmaceuticals Inc., 3 years.
Arrowhead Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 26, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −7,530 | $70.00 | $527,100 |
| Dec 16, 2025 | Arrowhead Pharmaceuticals Inc. | Grant or award | +7,819 | — | — |
| Nov 28, 2025 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −8,750 | $56.39 | $493,413 |
| Dec 18, 2024 | Arrowhead Pharmaceuticals Inc. | Grant or award | +16,733 | $22.99 | $384,692 |
| Jan 11, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −2,147 | $37.80 | $81,157 |
| Jan 11, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −1,000 | $38.63 | $38,630 |
| Dec 15, 2023 | Arrowhead Pharmaceuticals Inc. | Grant or award | +14,987 | $25.41 | $380,820 |
| Jan 10, 2023 | Arrowhead Pharmaceuticals Inc. | Grant or award | +7,867 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.